It is well-known in the medical field that the pig brain shares certain physiological and anatomical similarities with the human brain. So similar are the two that researchers at the University of Georgia’s Regenerative Bioscience Center have developed the first U.S. pig model for stroke treatments, which will provide essential preclinical data and speed the drug discovery process. (more…)
Two of the most influential bodies in Europe concerning stroke care are the European Stroke Organisation known as ESO, and the Stroke Alliance for Europe, commonly known as SAFE. And these two have joined forces earlier this year to support awareness, prevention and advocacy for improved stroke research and treatments. Stroke patients and those looking after them need to know that they have the safety, choice and empowerment as the guiding principles of care.
Please watch below the interview with Dr. Valeria Caso, neurologist from the University of Perugia, Italy, the President of ESO and John Barrick, the patient advocate and President of the Board of SAFE, the only European-wide alliance of stroke support organisations.
The full-length video is available if you click on the photo. (more…)
While immune cells called neutrophils are known to act as infantry in the body’s war on germs, a National Institutes of Health-funded study suggests they can act as medics as well. By studying rodents, researchers showed that instead of attacking germs, some neutrophils may help heal the brain after an intracerebral hemorrhage, a form of stroke caused by ruptured blood vessels. The study suggests that two neutrophil-related proteins may play critical roles in protecting the brain from stroke-induced damage and could be used as treatments for intracerebral hemorrhage.
“Intracerebral hemorrhage is a damaging and often fatal form of stroke for which there are no effective medicines,” said Jaroslaw Aronowski, M.D., Ph.D., professor, department of neurology, at the University of Texas Health Science Center at Houston, and senior author of the study published in Nature Communications. “Our results are a hopeful first step towards developing a treatment for this devastating form of stroke.” (more…)
The Economist Events and sponsor The Bristol-Myers Squibb and Pfizer Alliance hosted a webinar “Action on Stroke”, on September 21st 10:00 am EST/3:00 pm GMT, to address policy approaches to stroke prevention.
With heart disease and stroke as some of the leading causes of death worldwide, understanding the opportunity for policy to facilitate prevention is paramount.
– As there is a predicted increase in stroke incidence until 2030 in Europe and other parts of the world (Burden of Stroke Report and Global Burden of Disease Study) policy efforts on stroke prevention have to be increased (and SAFE as the patient voice in Europe is advocating for a better stroke prevention on the European level). – said Dr Markus Wagner, SAFE Vice President and one of the panelists at Action on Stroke – Live Webinar 2017 which happened on Wednesday, September 21st in London.
Please watch the entire webinar below:
After a stroke, many people are unable to successfully perform basic hand movements in everyday life. The reason are symptoms of hemiparesis resulting from damage to the brain. These very frequently affect fine motor skills. A team from the Technical University of Munich (TUM) is now paving the way to better diagnosis and more targeted therapy. (more…)
